Hall Laurie J Trustee Sarepta Therapeutics, Inc. Transaction History

Hall Laurie J Trustee

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$100.86 - $132.13 $2,017 - $2,642	-20 Reduced 33.33%	40 $5,000
Q3 2022 Oct 11, 2022	SELL	$75.71 - $119.24 $1,892 - $2,981	-25 Reduced 29.41%	60 $7,000
Q3 2021 Oct 04, 2021	SELL	$65.97 - $92.48 $3,298 - $4,624	-50 Reduced 37.04%	85 $8,000
Q1 2021 Apr 15, 2021	BUY	$72.25 - $168.95 $4,335 - $10,137	60 Added 80.0%	135 $10,000
Q3 2020 Oct 09, 2020	BUY	$127.12 - $172.34 $2,542 - $3,446	20 Added 36.36%	75 $11,000
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $765 - $1,355	10 Added 22.22%	55 $7,000
Q3 2019 Oct 25, 2019	SELL	$72.81 - $156.91 $1,820 - $3,922	-25 Reduced 35.71%	45 $3,000
Q2 2019 Aug 01, 2019	SELL	$112.21 - $151.95 $1,122 - $1,519	-10 Reduced 12.5%	70 $11,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $973 - $1,487	-10 Reduced 11.11%	80 $11,000
Q1 2018 May 10, 2018	SELL	$54.02 - $82.27 $172,864 - $263,264	-3,200 Reduced 97.26%	90 $7,000
Q4 2017 Jan 30, 2018	BUY	$47.64 - $56.75 $150,542 - $179,330	3,160 Added 2430.77%	3,290 $224,000
Q2 2017 Aug 22, 2017	BUY	N/A	130	130 $0

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.